MitraClip Device Automated Localization in 3D Transesophageal Echocardiography via Deep Learning
The MitraClip is the most widely percutaneous treatment for mitral regurgitation, typically performed under the real-time guidance of 3D transesophagel echocardiography (TEE). However, artifacts and low image contrast in echocardiography hinder accurate clip visualization. This study presents an aut...
Gespeichert in:
Hauptverfasser: | , , , , , , , , , |
---|---|
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The MitraClip is the most widely percutaneous treatment for mitral
regurgitation, typically performed under the real-time guidance of 3D
transesophagel echocardiography (TEE). However, artifacts and low image
contrast in echocardiography hinder accurate clip visualization. This study
presents an automated pipeline for clip detection from 3D TEE images. An
Attention UNet was employed to segment the device, while a DenseNet classifier
predicted its configuration among ten possible states, ranging from fully
closed to fully open. Based on the predicted configuration, a template model
derived from computer-aided design (CAD) was automatically registered to refine
the segmentation and enable quantitative characterization of the device. The
pipeline was trained and validated on 196 3D TEE images acquired using a heart
simulator, with ground-truth annotations refined through CAD-based templates.
The Attention UNet achieved an average surface distance of 0.76 mm and 95%
Hausdorff distance of 2.44 mm for segmentation, while the DenseNet achieved an
average weighted F1-score of 0.75 for classification. Post-refinement,
segmentation accuracy improved, with average surface distance and 95% Hausdorff
distance reduced to 0.75 mm and 2.05 mm, respectively. This pipeline enhanced
clip visualization, providing fast and accurate detection with quantitative
feedback, potentially improving procedural efficiency and reducing adverse
outcomes. |
---|---|
DOI: | 10.48550/arxiv.2412.15013 |